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Point: Dr Bennett
Th  e paper by Ge and colleagues from the Center for 
Sensory–Motor Interaction at Aalborg University, Den-
mark provides evidence that peripheral nociceptive input 
from muscle may be relevant to the contemporary 
understanding of ﬁ  bromyalgia (FM) [1].
Th  is study involved asking each subject (both FM 
patients and controls) to draw all areas of current spon-
taneous pain on an anatomical map and rate the overall 
intensity of pain. Th  e area of pain was quantiﬁ  ed  by 
digitization software. Th   e location of all active myofascial 
trigger points (MTPs) was then determined in the FM 
subjects using clinical palpation [2]. Altogether 308 active 
MTPs were found in the 30 FM subjects, and 305 of these 
were conﬁ   rmed by the demonstration of spontaneous 
elec  trical activity on needle electromyography (EMG). 
Th  e locations of these 308 active MTPs were then 
mirrored onto the 30 healthy controls as an aid to 
identifying latent MTPs; sponta  neous electrical activity 
was found in 304 of these latent MTPs. Th   e major MTP 
in each muscle was manually palpated at a pressure of 
about 4 kg for 10 seconds, and the location and area of 
referred pain was drawn by the subject and later digitized 
for subsequent analysis.
Th   e major ﬁ  ndings were as follows. Th   e intensity of the 
spontaneous pain in FM was strongly correlated with the 
total area of pain referred by manual palpation of MTPs. 
Manual stimulation of active MTPs in FM produces a 
local and referred pain pattern that is similar to the 
subject’s current spontaneous pain report. Th  e  locations 
of active MTPs in FM subjects were generally found to be 
the site of latent MTPs in the controls. Th  e overall 
number of MTPs was similar in both the FM patients and 
control subjects, but FM subjects had active MTPs 
whereas the controls’ MTPs were latent. Active MTPs in 
the FM subjects were most commonly found in the 
extensor digitorum, trapezius and infraspinatus in the 
upper body, and in the quadratus lumborum and gluteus 
medius in the lower body.
A critical issue in understanding Ge and colleagues’ 
paper is the distinction between active and latent MTPs. 
Ge and colleagues used the Travell and Simons recom-
men  dations for ﬁ   nding a MTP [2]; these specify that 
gentle palpation should be performed across the direc-
tion of the muscle ﬁ  bers in order to identify a region of 
tenderness and nodularity (that is, the taut band). Con-
tinued ﬁ  rm palpation of a MTP for at least 5 seconds is 
required to elicit the typical distribution of referred pain. 
An active MTP is deduced if ﬁ  rm pressure over the taut 
band reproduces the patient’s spontaneous pain symp-
toms. If the pain symptoms are not reproduced, the 
tender area is designated a latent trigger point. Latent 
MTPs are a common ﬁ  nding in healthy individuals, as is 
evident to anyone who has ever had a therapeutic massage.
Th  e Aalborg research group has a long record of 
productive research in the area of myofascial pain (MFP) 
and has recently presented evidence that most of the 18 
tender points used in the 1990 classiﬁ  cation criteria for 
FM have the characteristics of MTPs [3]. Over the past 
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sized a role for MTPs in the pathogenesis of FM [4-6]. 
Th  e lack of any generally acceptable criteria for repro-
ducibly locating MTPs has dissuaded many resear  chers 
from pursuing this avenue of investigation [7]. In the past 
5  years, however, there have been several studies that 
have provided a better scientiﬁ  c underpinning for under-
standing MTPs [8]: microdialysis has shown that MTPs 
have an acidic milieu containing pro-nociceptive mole-
cules; MTPs can be visualized as a hypoechogenic area 
using specialized ultrasound techniques; MTPs have 
been visualized with magnetic resonance elastography; 
the stimulation of MTPs may lead to central sensitization; 
stimulation of MTPs evokes activation of brain locations 
that have been associated with pain and emotional 
processing; and insertion of a concentric electrode into a 
MTP results in spontaneous electrical activity that can be 
visualized on EMG.
Currently FM is envisaged to be a pain syndrome 
related to dysfunctional central pain processing; however, 
increasingly evident is that peripheral pain generators 
such as painful joints and MTPs now need to be 
incorporated into this model [9]. A more widespread 
acceptance of MTPs and other peripheral pain generators 
as potential initiators and perpetuators of central sensi-
tization would be an important paradigm shift in our 
current understanding of FM. Th   e relevance of MTPs is 
gaining increasing attention, and Ge and colleagues’ 
results have now been replicated in a study from Spain 
[10]. Future research in this area will have important 
implications for the development of updated diagnostic 
criteria and the comprehensive treatment of FM patients 
[11].
Counterpoint: Dr Goldenberg
Th  e  signiﬁ  cance of Ge and colleagues’ study is tempered 
by concerns with the validity of MTPs [1]. Th  ere is no 
widely agreed-upon deﬁ   nition of MTPs. Ge and 
colleagues used the Travell and Simons’ criteria, as noted 
by Bennett. Tough and colleagues, however, found 19 
diﬀ  erent diagnostic criteria for MTP pain in an extensive 
literature review [12]. Most of those studies cited the 
work by Travell and Simons yet failed to apply their 
diagnostic criteria. Th  e systematic review by Lucas and 
colleagues concluded: ‘On the basis of the limited number 
of studies available, and signiﬁ  cant problems with their 
design, reporting, statistical integrity, and clinical 
applicability, physical examination cannot currently be 
recommended as a reliable test for the diagnosis of 
trigger points’ [13].
Th   ere is signiﬁ  cant interobserver variability in the MTP 
examination. For example, four rheumatologists, includ  ing 
Bennett and myself, and four experts on MFP syndrome 
performed trigger point and tender point examinations 
on three groups of subjects (seven patients with FM, 
eight patients with MFP, and eight healthy persons) while 
blinded as regards diagnosis [14]. Active MTPs were 
found in 18% of patients with FM and MFP, but latent 
trigger points were rare in all groups. Taut muscle bands 
and muscle twitches were common (50% and 30%, 
respectively) and were noted equally in all three diag-
nostic groups. Th  ere were signiﬁ   cant problems with 
interobserver reliability for taut bands, muscle twitch and 
active trigger points. Th  e interexaminer reproducibility 
of the MTP examination varies even among experts but 
improves with a standardized technique and experience 
[15,16]. Palpation of taut bands and muscle-snapping tech-
niques are especially prone to interobserver variability.
MFP experts point to electrophysiologic evidence of 
muscle pathology. Ge and colleagues report that EMG 
evidence of spontaneous electrical activity is the only 
electrophysiological method to document the existence 
of MTP, and they therefore used this technique [1]. In 
their study, the EMG was performed after the manual 
exami  nation, the needle was ‘redirected twice if the ﬁ  rst 
insertion failed to ﬁ  nd the spontaneous electrical activity’ 
and the needle electrode length varied with diﬀ  erent 
muscles. Some investigators have been unable to ﬁ  nd 
characteristic spontaneous EMG activity in MTPs [17]. 
Other techniques said to demonstrate abnormalities in 
the MTP, such as microdialysis, magnetic resonance 
elastography and specialized ultrasound, are not widely 
available and the results have not been duplicated.
Although MFP is considered a localized muscle pain 
disorder, there is considerable clinical overlap with FM. 
Two studies reported that 25 to 42% of subjects with 
chronic cervical MFP met diagnostic criteria for FM 
[18,19], and two reports found that 75 to 80% of FM 
patients met the criteria for MFP [19,20].
Th  ere is strong evidence that abnormal central pain 
processing, characteristic of FM, is also prominent in 
MFP. Similar somatosensory pain proﬁ  les are found in 
both FM and MFP [21], and women with MFP had 
bilateral widespread mechanical pain sensitivity [22]. 
Bennett mentioned above that sustained mechanical 
stimulation of latent MTPs induced central sensitization 
in healthy subjects [14,15]. What makes that diﬀ  erent 
from mechanical pressure on tender points inducing 
central pain? Both Bennett and Ge and colleagues 
mention that proinﬂ   ammatory mediators have been 
reported in MTPs. Similar observations have been found 
in FM. De Stefano and colleagues found evidence for 
elevated substance-P immunoreactivity in both MFP and 
FM [23].
MFP is postulated to be typically self-limited whereas 
FM is postulated as chronic. FM patients are said to have 
greater co-morbidity and other somatic symptoms, such 
as fatigue and sleep and mood disturbances. Th  is 
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MFP experts claim that localized therapy, particularly 
trigger point injections, are very eﬀ  ective for MTPs but 
not for tender points. Unfortunately, there are no 
randomized, controlled studies to document this belief. 
Th  e un  con  trolled studies of multiple diﬀ  erent injection 
techniques, diﬀ  erent injec  table agents, dry needling and 
physical modalities attest to lack of universal success. A 
large, multicenter pros  pective study comparing subjects 
who meet criteria for FM, for MFP and for both 
conditions would be necessary.
Finally, there is no convincing evidence that the MTP 
can be clinically or pathophysiolgically distinguished 
from a FM tender point. No study has matched painful 
muscles containing only tender points with those con-
taining only trigger points. Since trigger points always 
have a tender point, such a study seems impossible.
Just like ﬁ  brositis and ﬁ  bositic nodules have become 
historical curiosities, MTPs will eventually be discounted 
as discrete pathologic abnormalities in the muscle. MFP 
will be brought into the realm of central pain disorders, 
including chronic headaches, irritable bowel syndrome, 
temporomandibular dysfunction and FM. Th  e  likelihood 
that MFP will spread to FM will be attributed to central 
factors, such as generalized pain tolerance, co-morbid 
illness and psychosocial factors. Identifying and treating 
any peripheral pain is a noble pursuit in the management 
of central pain disorders, such as FM. However, it is 
unlikely that the MTP is a speciﬁ   c peripheral pain 
phenomenon.
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